De Rosa Laura L

Show results for

Unknown (25)
Transcriptomics (12)
Metabolomics (2)

Organisms

Homo sapiens (11)
Mus musculus (1)

Repository

biostudies-arrayexpress (12)
MetaboLights (2)

Disease

Chronic lymphocytic leukemia (3)
ACUTE MYELOID LEUKEMIA (2)
Normal (2)
Breast Normal (1)
CHRONIC LYMPHOCYTIC LEUKEMIA (1)
NORMAL (1)

Technology Type

Mass spectrometry (2)

Instrument Platform

Axon GenePix 4000B scanner (1)
ScanArray 4000XL [PerkinElmer] (1)
Scanning hardware (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)
Q Exactive (1)

Publication Date

2010 (7)
2005 (2)
2022 (2)
2012 (1)
2011 (1)
2009 (1)

CHEBI ID

CHEBI:15428 (2)
CHEBI:15611 (2)
CHEBI:15698 (2)
CHEBI:15728 (2)
CHEBI:15891 (2)
CHEBI:15978 (2)
CHEBI:15999 (2)
CHEBI:16020 (2)
CHEBI:16199 (2)
CHEBI:16335 (2)
CHEBI:16359 (2)
CHEBI:16450 (2)
CHEBI:16530 (2)
CHEBI:16628 (2)
CHEBI:16668 (2)
CHEBI:16675 (2)
CHEBI:16704 (2)
CHEBI:16708 (2)
CHEBI:16737 (2)
CHEBI:16750 (2)
CHEBI:16827 (2)
CHEBI:16919 (2)
CHEBI:17012 (2)
CHEBI:17050 (2)
CHEBI:17140 (2)
CHEBI:17154 (2)
CHEBI:17172 (2)
CHEBI:172453 (2)
CHEBI:17287 (2)
CHEBI:17385 (2)

Metabolite Name

O-Tyrosine (2)
(R)-3-hydroxybutyrylcarnitine (1)
1,11-Undecanedicarboxylic acid (1)
1,3-Dimethyluric acid (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)* (1)
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)* (1)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)* (1)
1-(1-enyl-palmitoyl)-GPE (P-16:0)* (1)
1-(1-enyl-stearoyl)-GPE (P-18:0)* (1)
1-arachidonoyl-GPI (20:4)* (1)
1-lignoceroyl-GPC (24:0) (1)
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)* (1)
1-linoleoyl-GPC (18:2) (1)
1-linoleoyl-GPE (18:2)* (1)
1-methyl-4-imidazoleacetate (1)
1-methylguanidine (1)
1-methylhistamine (1)
1-methylhistidine (1)
1-methylnicotinamide (1)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) (1)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (1)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)* (1)
1-oleoyl-GPI (18:1) (1)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* (1)
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) (1)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)* (1)
1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) (1)
1-palmitoyl-2-oleoyl-GPC (16:0/18:1) (1)
1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)* (1)

Study type

MicroRNA profiling by array (9)
Transcription profiling by array (3)

Release Date

2010 (7)
2021 (6)
2023 (5)
2022 (5)
2017 (3)
2011 (2)
2005 (2)
2025 (2)
2024 (2)
2012 (1)
2009 (1)
2015 (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Xenograft assays)

Glioblastoma (GBM) is a common and deadly form of brain tumor in adults. Dysregulated metabolism in GBM offers an opportunity to deploy metabolic interventions as precise therapeutic strategies. To identify the molecular drivers and the modalities by which different molecular subgroups of GBM exp...

2022-11-08 | MTBLS730 | MetaboLights

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Stem cell and cell line assays)

2022-11-08 | MTBLS4708 | MetaboLights

Developing Visual Messages to Support Liquefied Petroleum Gas Use in Intervention Homes in the Household Air Pollution Intervention Network (HAPIN) Trial in Rural Guatemala.

Not available

S-EPMC10666197 | biostudies-literature

MicroRNA profiling of human chronic lymphocytic leukemia samples to identify whether microRNA profiles are prognostic indicators

MicroRNA expression profiles can distinguish normal B cells from malignant B cells in chronic lymphocytic leukemia (CLL). We investigated whether microRNA profiles are associated with known prognostic factors in CLL. We evaluated the microRNA expression profiles of 94 samples of CLL cells for which ...

ORGANISM(S): Homo sapiens

2005-10-27 | E-TABM-41 | biostudies-arrayexpress

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Not available

S-EPMC8050319 | biostudies-literature

Transcription profiling of human chronic lymphocytic leukemia miRNA expression validation

MicroRNA expression profiles can distinguish normal B cells from malignant B cells in chronic lymphocytic leukemia (CLL). We investigated whether microRNA profiles are associated with known prognostic factors in CLL. We evaluated the microRNa expression profiles of 94 samples of CLL cells for which ...

ORGANISM(S): Homo sapiens

2005-10-27 | E-TABM-42 | biostudies-arrayexpress

MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities (OSU-CCC microRNA array)

We studied the value of the microRNAs as a signature for CLL patients with specific chromosomal abnormalities. We identified 32 microRNAs able to discriminate the 11q deletion, 17p deletion, trisomy 12, and 13q deletion and normal karyotype cytogenetic subgroups. The expression values of 9 among the...

ORGANISM(S): Homo sapiens

2009-10-01 | E-TABM-762 | biostudies-arrayexpress

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials.

Not available

S-EPMC8605464 | biostudies-literature

Transcriptomic analysis of the cerebellum of daDREAM mice

DREAM (downstream regulatory element antagonist modulator) is a Ca2+-binding protein that binds DNA and represses transcription in a Ca2+-dependent manner. Previous studies have shown a role for DREAM in cerebellar function regulating the expression of the sodium/calcium exchanger3 (NCX3) in cerebel...

ORGANISM(S): Mus musculus

2012-09-30 | E-GEOD-34765 | biostudies-arrayexpress

Evidence-Based Checklist to Delay Cardiac Arrest in Brain-Dead Potential Organ Donors: The DONORS Cluster Randomized Clinical Trial.

Not available

S-EPMC10722341 | biostudies-literature

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

39 Results

Show results for

Organisms

Repository

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets